Skip to main content
SpringerLink
Log in

Types of Circulatory Support Devices

  • Chapter
  • First Online:
Heart Failure

Part of the book series: Cardiovascular Medicine ((CVM))

Abstract

There are many conceptual ways to consider the devices intended to support the circulation: the indication for implantation, type of device, the ventricles supported, the anticipated duration of support and the acuity of patient need. For example, devices used to support a patient in cardiogenic shock following an acute myocardial infarction are different from those used to treat a patient in chronic advanced heart failure who will live permanently on a device. In the remainder of this chapter, mechanical circulatory support devices will be presented as those intended for either short- or long-term support.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006;97:1391–8.

    Article  Google Scholar 

  2. Santa-Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv. 2006;67:68–77.

    Article  Google Scholar 

  3. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM. For the investigators in the National Registry of myocardial infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complication acute myocardial infarction: data from the National Registry of myocardial infarction 2. Am Heart J. 2001;141:933–9.

    Article  CAS  Google Scholar 

  4. Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esenta P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Grines L, O’Neill WW, Grines C. A prospective, randomized evaluation of prophylactic intra-aortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997;29:1459–67.

    Article  CAS  Google Scholar 

  5. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebelt H, Schneider S, Schuler G, Werdan K. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287–96.

    Article  CAS  Google Scholar 

  6. Estep JD, Cordero-Reyes AM, Bhimaraj A, Trachtenberg B, Khalil N, Loebe M, Bruckner B, Orrego CM, Bismuth J, Kleiman NS, Torre-Amione G. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail. 2013;1:382–8.

    Article  Google Scholar 

  7. Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall S. Effectiveness and safety of the Impella 5.0 as a bridge to transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117:1622–8.

    Article  Google Scholar 

  8. O’Neill WW, Kleiman BS, Moses J, et al. A prospective randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. The PROTECT II study. Circulation. 2012;126:1717–27.

    Article  Google Scholar 

  9. Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJS, Vis MM, Wykrzkowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol B, Tijssen JGP, Henriques JPS. Impella CP versus intra-aotic balloon pump in acute myocardial infarction complicated by cardiogenic shock: The IMPRESS trial. J Am Coll Cardiol. 2016; ePub ahead of print.

    Google Scholar 

  10. Ouweneel DM, Eriksen E, Seyfarth M, Henriques JPS. Impella versus intra-aortic balloon pump for the treatment of cardiogenic shock: a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2016; ePub ahead of print.

    Google Scholar 

  11. Griffith BP, Anderson MB, Samuels LE, et al. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg. 2013;145:548–54.

    Article  Google Scholar 

  12. Anderson MB, Goldstein J, Milano CA, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O’Neill W. Benefits of a novel percutaneous ventricular assist device for the right heart: the prospective RECOVER RIGHT study of the IMPELLA RP device. J Heart Lung Transplant. 2015;34:1549–60.

    Article  Google Scholar 

  13. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688–96.

    Article  Google Scholar 

  14. Allen S, Holena D, McCunn M, Kohl B, Sarani B. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically III adult patients. J Intensive Care Med. 2011;26:13–26.

    Article  Google Scholar 

  15. Bougouin W, Aissaoui N, Combes A, Deye N, Lamhaut L, Jost D, Maupain C, Beganton F, Bougle A, Karam N, Dumas F, Marijon E, Jouven X, Cariou A, on behalf SDEC Investigators. Post-cardiac arrest shock treated with veno-arterial extracorporeal membrane oxygenation An observational study and propensity analysis. Resuscitation. 2017;110:126–32.

    Article  Google Scholar 

  16. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaroonson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.

    Article  CAS  Google Scholar 

  17. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.

    Article  CAS  Google Scholar 

  18. Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, Kasirijan V, Haas DC, O’Connell JB, Boyle AJ, Farrar DJ, Rogers JG. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients. J Am Coll Cardiol. 2015;66:1747–61.

    Article  Google Scholar 

  19. Netuka I, Sood P, Pya Y ZD, Krabatsch T, Gaargade J, Rao V, Morshuis M, Marasco S, Beyersdorf J, Damme L, Schmitto JD. Fully magnetically levitated left ventricular assist system for treating advanced heart failure. J Am Coll Cardiol. 2015;66:2579–89.

    Article  Google Scholar 

  20. Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC, Colombo PC, Walsh MN, Milarno CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2016; ePub ahead of print.

    Google Scholar 

  21. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL, Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce SW, for the HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.

    Article  Google Scholar 

  22. Rogers JG, Pagani FD, Tatooles AJ, Bhat G, Slaughter MS, Birks EJ, Boyce SW, Najjar SS, Jeevanandam V, Anderson AS, Gregoric ID, Mallidi H, Leadley K, Aaronson KD, Frazier OH, Milano CAIntra-pericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376:451–60.

    Article  Google Scholar 

  23. Teuteberg JJ, Slaughter MS, Rogers JG, McGee EC, Pagani FD, Gordon R, Rame E, Acker M, Kormos RL, Salerno C, Schleeter TP, Goldstein DJ, Shin J, Starling RC, Wozniak T, Malik AS, Silvestry S, Ewald GA, Jorde UP, Naka Y, Birks E, Najarian KB, Hathaway DR, Aaronson KD, for the ADVANCE Investigators. The HVAD left ventricular assist device. Risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3:818–28.

    Article  Google Scholar 

  24. Fraser CD, Jaquiss R, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte P, Turrentine MW, Cohen GA, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS, for the Berlin Heart Study Investigators. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367:532–41.

    Article  CAS  Google Scholar 

  25. Mohacsi P, Leprince P. The CARMAT total artificial heart. Eur J Cardiothorac Surg. 2014;46:933–4.

    Article  Google Scholar 

  26. Goerlich CE, Frazier OH, Cohn WE. Previous challenges and current progress – the use of total artificial heart in patients with end-stage heart failure. Expert Rev Cardiovasc Ther. 2016;14:1095–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Duke University, Durham, NC, USA

    Joseph G. Rogers

Authors
  1. Joseph G. Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph G. Rogers .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA

    David S. Feldman

  2. Clinic im Park, Cardiovascular Center Zürich, Hirslanden Zurich, Switzerland

    Paul Mohacsi

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rogers, J.G. (2019). Types of Circulatory Support Devices. In: Feldman, D., Mohacsi, P. (eds) Heart Failure. Cardiovascular Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-98184-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98184-0_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98182-6

  • Online ISBN: 978-3-319-98184-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation